Metagenomi Therapeutics, Inc. Common Stock

MGX us
$1.15
▲ +0.00 (+0.00%)
Volume: 70,755 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 32
  • 21d momentum -5.7%
  • MA aligned bearish
  • RSI 46
🎯 Pullback 50
  • +0.0% vs 20MA
💎 Value 58
  • -71% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)46.1
MACD+0.002
MA trendBearish
ATR3.78%
21d mom.-5.7%
63d mom.-8.0%
vs 20MA+0.0%
RVOL(20)0.45×
52w low · 1 52w high · 4
-70.9% from 52-week high
20d support 1 · resistance 1

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$43M
PER—
PBR0.39
PSR3.20
EPS$-2.47
ROE-83.0%
ROA-53.8%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-0.05
week1M3M6M1YYTD
+4.55% -5.74% -8.00% -17.27% -44.98% -31.14%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
5/10
🐻 Bear
6/10

14d momentum -1.71%, daily vol 1.54%. Metagenomi Therapeutics, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.